GTG shares soar on back of Applera lawsuit news
Monday, 20 September, 2004
The share price of Genetic Technologies (ASX: GTG) has risen over 50 per cent since the judge in GTG's lawsuit against Applera ruled largely in the company's favour during the Markman hearing last Thursday.
GTG were up from AUD$0.38 last Thursday to AUD$0.59 at time of writing.
In the hearing, the court examined 15 disputed technical terms within GTG's patent claims, ruling in favour of GTG's definition in 13 cases, and adopting a definition consistent with GTG's position for the other two terms.
SEQ koala population carries immunity to retrovirus
Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...
RSV immunisation program for babies slashes hospital stays
An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...
A targeted treatment option for psoriasis
New research from MedUni Vienna paves the way for the development of a therapy that not only...
